The HinduHealth
Nucelion to make VeGen Bio’s multiple myeloma therapy
Nucelion, Bharat Biotech’s arm, will support VeGen Bio’s experimental cell therapy VL-2511 for multiple myeloma. Its role includes technology transfer and manufacturing for clinical development, with commercial production possible if the treatment is approved in the future.
This card is an AI-assisted summary of reporting published by The Hindu. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.